nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant 131I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial
|
Li, Jun |
|
|
5 |
6 |
p. 548-560 |
artikel |
2 |
Adjuvant 131I-metuximab in hepatocellular carcinoma: a new option for an old drug?
|
Vogel, Arndt |
|
|
5 |
6 |
p. 517-519 |
artikel |
3 |
A global perspective on oesophageal cancer: two diseases in one
|
Ho, Andrew L K |
|
|
5 |
6 |
p. 521-522 |
artikel |
4 |
Assessing the impact of lowering the colorectal cancer screening age to 45 years
|
Liang, Peter S |
|
|
5 |
6 |
p. 523-524 |
artikel |
5 |
Correction to Lancet Gastroenterol Hepatol 2020; 5: 430–31
|
|
|
|
5 |
6 |
p. e5 |
artikel |
6 |
COVID-19 and the liver: little cause for concern
|
Bangash, Mansoor N |
|
|
5 |
6 |
p. 529-530 |
artikel |
7 |
COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy
|
Bhoori, Sherrie |
|
|
5 |
6 |
p. 532-533 |
artikel |
8 |
Eliminating HCV: a marathon, not a sprint
|
The Lancet Gastroenterology & Hepatology, |
|
|
5 |
6 |
p. 515 |
artikel |
9 |
Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period
|
Iacucci, Marietta |
|
|
5 |
6 |
p. 598-606 |
artikel |
10 |
Enteric involvement in hospitalised patients with COVID-19 outside Wuhan
|
Wan, Yunle |
|
|
5 |
6 |
p. 534-535 |
artikel |
11 |
Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China
|
An, Ping |
|
|
5 |
6 |
p. 525-527 |
artikel |
12 |
Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis
|
Xiao, Yong |
|
|
5 |
6 |
p. 528-529 |
artikel |
13 |
Research in brief
|
Baker, Holly |
|
|
5 |
6 |
p. 536 |
artikel |
14 |
Risk of colorectal cancer incidence and mortality after polypectomy: a Swedish record-linkage study
|
Song, Mingyang |
|
|
5 |
6 |
p. 537-547 |
artikel |
15 |
SARS-CoV-2 in wastewater: potential health risk, but also data source
|
Lodder, Willemijn |
|
|
5 |
6 |
p. 533-534 |
artikel |
16 |
Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward
|
Green, Christopher A |
|
|
5 |
6 |
p. 531 |
artikel |
17 |
Sessile serrated polyps and colorectal cancer mortality
|
Meester, Reinier G S |
|
|
5 |
6 |
p. 516-517 |
artikel |
18 |
Stigma and irritable bowel syndrome: a taboo subject?
|
Hearn, Mark |
|
|
5 |
6 |
p. 607-615 |
artikel |
19 |
The effect of sleep on gastrointestinal functioning in common digestive diseases
|
Orr, William C |
|
|
5 |
6 |
p. 616-624 |
artikel |
20 |
The global burden of gastro-oesophageal reflux disease: more than just heartburn and regurgitation
|
Sweis, Rami |
|
|
5 |
6 |
p. 519-521 |
artikel |
21 |
The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|
|
|
|
5 |
6 |
p. 561-581 |
artikel |
22 |
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|
|
|
|
5 |
6 |
p. 582-597 |
artikel |
23 |
Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak
|
Zingone, Fabiana |
|
|
5 |
6 |
p. 525 |
artikel |